Viewing nowFolgazene 5mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Nexfarm Korea Co., Ltd.

MFDS item code 202302482 · Approved 2023.08.22 · Insurance code 662504920
Treatment for glycemic control in type 2 diabetes and reduction of cardiovascular risk in chronic heart failure and kidney disease
This medication is used in combination with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It also helps reduce the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. Additionally, it is effective in decreasing the risk of worsening kidney function and cardiovascular mortality in patients with chronic kidney disease. This medication is used alongside standard treatment for each condition and is administered appropriately according to the patient’s condition. In summary, this medication is used for the treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease.
This medication can be taken orally once daily at any time during the day, regardless of food intake. The tablet should be swallowed whole.
Efficacy and safety of dapagliflozin in children under 18 years have not been established. There are no relevant data.
This medication should not be administered to certain patients. Patients allergic to the active ingredient or excipients of this medication, those with type 1 diabetes, diabetic ketoacidosis, lactate intolerance or related genetic diseases, and patients undergoing dialysis should not use this medication. It should be administered with caution to patients with decreased fluid volume or renal function issues. This medication can cause low blood pressure or rapid changes in kidney function, particularly in elderly patients with impaired renal function or those taking diuretics, increasing their risk. Therefore, fluid status and renal function should be assessed prior to administration, and symptoms of hypotension and kidney function should be monitored periodically after administration. This medication is not recommended for patients with severely reduced renal function, and its effect on blood sugar control varies according to renal function. While taking this medication, side effects such as genital infections, urinary tract infections, hypoglycemia, dehydration, and diabetic ketoacidosis may occur. Especially, genital infections are more common in females, with a higher chance of recurrence in those with a history of infections. Hypoglycemia may occur primarily when taken with insulin or sulfonylureas, so dosage adjustments may be necessary when used in combination with these medications. Dehydration or hypotensive symptoms may occur due to decreased fluid volume, so immediate consultation with healthcare professionals is necessary if these symptoms appear. Diabetic ketoacidosis can occur even if blood sugar levels are not high, so if symptoms such as vomiting, abdominal pain, or difficulty breathing occur, immediate examination and treatment are required. This medication is not recommended for patients with severely impaired liver function, and additional caution is needed for elderly patients or those on diuretics. Furthermore, it is advised not to use this medication during pregnancy and to avoid use while breastfeeding. This medication may interact with other drugs, so inform healthcare professionals, especially if you are taking diuretics, insulin, or sulfonylureas. In case of overdose, there is no specific antidote, so treatment should be provided according to the symptoms, and immediate contact with a medical institution is necessary if needed. Finally, the safety and efficacy of this medication have not been established in children and should not be used in pediatric patients. While taking this medication, caution is needed when driving or operating machinery to account for the risk of hypoglycemia. This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and should be kept at room temperature between 1°C and 30°C.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C.
Yellow, biconvex, round film-coated tablet
Domestic - 30 tablets/bottle, Export - 28 tablets/box [(7 tablets/Alu-Alu) x 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Nexfarm Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.